Sonnet BioTherapeutics I... (SONN)
Company Description
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action.
The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues.
Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer.
The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy.
It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6.
Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.
| Country | United States |
| IPO Date | Oct 31, 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 13 |
| CEO | Dr. Pankaj Mohan Ph.D. |
Contact Details
Address: 100 Overlook Center Princeton, New Jersey United States | |
| Website | https://www.sonnetbio.com |
Stock Details
| Ticker Symbol | SONN |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001106838 |
| CUSIP Number | 83548R105 |
| ISIN Number | US83548R3030 |
| Employer ID | 52-2102141 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Pankaj Mohan Ph.D. | Founder, Chairman, Chief Executive Officer & President |
| Donald J. Griffith CPA, CPA | Chief Financial Officer, Financial Controller & Director |
| Dr. Gael Hedou Ph.D. | Chief Operating Officer |
| Dr. John K. Cini Ph.D. | Chief Scientific Officer & Co-Founder |
| Dr. Richard T. Kenney FACP, M.D. | Chief Medical Officer |
| Dr. Stephen J. McAndrew Ph.D. | Chief Business Officer |
| Manuel Dafonseca | Head of Clinical Operations |
| Susan Dexter | Chief Technical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 01, 2025 | 8-K | Current Report |
| Mar 26, 2025 | 8-K | Current Report |
| Mar 19, 2025 | 8-K | Current Report |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 21, 2025 | 3 | Filing |
| Feb 19, 2025 | 8-K | Current Report |
| Feb 13, 2025 | 10-Q | Quarterly Report |
| Feb 13, 2025 | 8-K | Current Report |
| Jan 31, 2025 | 424B3 | Filing |
| Jan 31, 2025 | 424B3 | Filing |